Back to Search
Start Over
985P A phase II study of camrelizumab for advanced hepatocellular carcinoma: Two-year outcomes and continued treatment beyond RECIST-defined progression.
- Source :
-
Annals of Oncology . 2020 Supplement 4, Vol. 31, pS689-S690. 2p. - Publication Year :
- 2020
- Subjects :
- *HEPATOCELLULAR carcinoma
*TREATMENT effectiveness
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152695636
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.1101